Intec Parent Inc. (NTEC) NASDAQ CAPITAL MARKET
$9.63 - (-)
Market Cap: $70.98M
As of 08/03/21 12:00 AM EDT. Market closed.
Intec Parent Inc. (NTEC)
NASDAQ CAPITAL MARKET
$9.63
- (-)
Market Cap: $70.98M
As of 08/03/21 12:00 AM EDT. Market closed.
Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release ... read more
Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Dexcel Pharma Technologies Ltd. | 10% Owner | Jan 31, 2020 | Sale | $0.31 | 725,951 | 224,319 | 4,424,897 | Feb 04, 2020, 06:41 PM |
Dexcel Pharma Technologies Ltd. | 10% Owner | Feb 04, 2020 | Sale | $0.29 | 110,000 | 31,900 | 4,234,897 | Feb 04, 2020, 06:41 PM |
Dexcel Pharma Technologies Ltd. | 10% Owner | Feb 03, 2020 | Sale | $0.32 | 80,000 | 25,440 | 4,344,897 | Feb 04, 2020, 06:41 PM |
Silberman Issac | Director | Nov 19, 2019 | Sale | $0.50 | 1,000 | 504 | 4,000 | Nov 21, 2019, 05:00 PM |
Meckler Jeffrey A | Chief Executive Officer | Aug 28, 2019 | Buy | $0.68 | 20,000 | 13,620 | 196,761 | Aug 29, 2019, 04:16 PM |
MADDALUNA ANTHONY J | Director | Aug 27, 2019 | Buy | $0.47 | 25,000 | 11,750 | 53,570 | Aug 29, 2019, 04:16 PM |
KOZARICH JOHN W | Director | Aug 23, 2019 | Buy | $0.46 | 100,000 | 45,900 | 151,761 | Aug 27, 2019, 04:20 PM |
Meckler Jeffrey A | Chief Executive Officer | Aug 23, 2019 | Buy | $0.46 | 100,000 | 45,700 | 176,761 | Aug 27, 2019, 04:18 PM |
Owner | Relationship | Date | Value($) |
Dexcel Pharma Technologies Ltd. | 10% Owner | 01/31/2020 | 224,319 |
Dexcel Pharma Technologies Ltd. | 10% Owner | 02/04/2020 | 31,900 |
Dexcel Pharma Technologies Ltd. | 10% Owner | 02/03/2020 | 25,440 |
Silberman Issac | Director | 11/19/2019 | 504 |
Meckler Jeffrey A | Chief Executive Officer | 08/28/2019 | 13,620 |
MADDALUNA ANTHONY J | Director | 08/27/2019 | 11,750 |
KOZARICH JOHN W | Director | 08/23/2019 | 45,900 |
Meckler Jeffrey A | Chief Executive Officer | 08/23/2019 | 45,700 |